AU538131B2 - Lonidamine in cancer treatment - Google Patents

Lonidamine in cancer treatment

Info

Publication number
AU538131B2
AU538131B2 AU87156/82A AU8715682A AU538131B2 AU 538131 B2 AU538131 B2 AU 538131B2 AU 87156/82 A AU87156/82 A AU 87156/82A AU 8715682 A AU8715682 A AU 8715682A AU 538131 B2 AU538131 B2 AU 538131B2
Authority
AU
Australia
Prior art keywords
lonidamine
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU87156/82A
Other versions
AU8715682A (en
Inventor
Bruno Silvestrini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of AU8715682A publication Critical patent/AU8715682A/en
Application granted granted Critical
Publication of AU538131B2 publication Critical patent/AU538131B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU87156/82A 1981-08-17 1982-08-13 Lonidamine in cancer treatment Ceased AU538131B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8123542A IT1211101B (en) 1981-08-17 1981-08-17 USE OF LONIDAMINE IN CANCERS.
IT2354281 1981-08-17

Publications (2)

Publication Number Publication Date
AU8715682A AU8715682A (en) 1983-02-24
AU538131B2 true AU538131B2 (en) 1984-08-02

Family

ID=11207989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87156/82A Ceased AU538131B2 (en) 1981-08-17 1982-08-13 Lonidamine in cancer treatment

Country Status (7)

Country Link
JP (1) JPS5869814A (en)
AU (1) AU538131B2 (en)
BE (1) BE894111A (en)
IE (1) IE54256B1 (en)
IL (1) IL66159A0 (en)
IT (1) IT1211101B (en)
PH (1) PH24435A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919939B2 (en) * 1972-02-29 1984-05-09 アジエンテ キミケ リウニテ アンジエリニ フランチエスコ ア シ エル ア エフ エス ピ ア Method for producing 1-benzyl-1H-indazole-3-carboxylic acid derivative

Also Published As

Publication number Publication date
IT8123542A0 (en) 1981-08-17
IT1211101B (en) 1989-09-29
AU8715682A (en) 1983-02-24
BE894111A (en) 1982-12-01
PH24435A (en) 1990-06-25
IE821581L (en) 1983-02-17
IE54256B1 (en) 1989-08-02
IL66159A0 (en) 1982-09-30
JPS5869814A (en) 1983-04-26

Similar Documents

Publication Publication Date Title
GB2108851B (en) Beauty treatment
AU538595B2 (en) Parallel processing
AU560184B2 (en) Polyampholites and their use
AU4595985A (en) Cancer treatment
EP0172721A3 (en) Use of phlorizin or its derivatives in the treatment of cancer
AU544638B2 (en) Processed starch and its use in medicine
AU547803B2 (en) s
JPS57171767A (en) Sizining treatment
AU559138B2 (en) Modulating and processing signals in pacemaker
JPS57194101A (en) Revolving body
AU5912886A (en) Tumor treatment in warm-blooded animals
AU8248182A (en) Wastewater treatment
AU528710B2 (en) Hexahydro-trans and tetrahydropyridoindole
ZA826057B (en) Improvements in surgical devices
AU544005B2 (en) Cache buffer-pageing
AU1570083A (en) Surface treatment
AU538131B2 (en) Lonidamine in cancer treatment
AU596067B2 (en) Wheelchairs
AU1652383A (en) Pharmaceutical composition comprising xipamide and alpha- methyldopa
AU6671090A (en) Cancer treatments
JPS5728088A (en) Olibacine derivative and cancer therapy
AU551058B2 (en) Surface treatment
AU527958B2 (en) Cancer treatment
AU559170B2 (en) Cloxacillin treatment
ZA899631B (en) Cancer treatment